RINDI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 2.433
EU - Europa 1.910
AS - Asia 820
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 5.175
Nazione #
US - Stati Uniti d'America 2.358
CN - Cina 632
UA - Ucraina 459
IE - Irlanda 444
SE - Svezia 347
FI - Finlandia 304
DE - Germania 204
SG - Singapore 93
CA - Canada 73
GB - Regno Unito 66
TR - Turchia 53
IT - Italia 47
IN - India 34
BE - Belgio 15
CZ - Repubblica Ceca 9
EU - Europa 7
FR - Francia 7
CI - Costa d'Avorio 3
JP - Giappone 3
MX - Messico 2
RU - Federazione Russa 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
Totale 5.175
Città #
Chandler 464
Jacksonville 451
Dublin 443
Dearborn 244
Beijing 184
Ashburn 122
Nanjing 121
Princeton 100
San Mateo 97
Ann Arbor 78
Toronto 64
Wilmington 62
Singapore 53
Izmir 50
Helsinki 42
Boardman 36
Nanchang 32
Shanghai 32
Hebei 30
Pune 30
Kunming 28
Shenyang 26
Jinan 24
Woodbridge 20
Hefei 18
New York 18
Tianjin 17
Los Angeles 16
Brussels 15
Changsha 14
Jiaxing 11
Norwalk 11
Guangzhou 9
Hangzhou 9
Borås 8
Des Moines 8
Parma 8
Zhengzhou 8
Auburn Hills 7
Bremen 7
Brno 7
Fremont 7
Dallas 6
Taiyuan 6
London 5
Rockville 5
Seattle 5
Fuzhou 4
Grafing 4
Haikou 4
Ningbo 4
Abidjan 3
Baotou 3
Bologna 3
Kocaeli 3
Kyiv 3
New Orleans 3
Ottawa 3
Rio Saliceto 3
Wenzhou 3
Augusta 2
Carate Brianza 2
Changchun 2
Chengdu 2
Dong Ket 2
Düsseldorf 2
Forest City 2
Guwahati 2
Lanzhou 2
Mola Di Bari 2
Montréal 2
Paris 2
Quzhou 2
Selvazzano Dentro 2
Stockholm 2
Taizhou 2
Wuhan 2
Xian 2
Andover 1
Ardabil 1
Avoca 1
Bari 1
Bethany 1
Brampton 1
Budapest 1
Chicago 1
Chongqing 1
Clarks Summit 1
Clifton 1
Columbus 1
Delhi 1
Edinburgh 1
Finchley 1
Garza García 1
Geelong 1
Geislingen an der Steige 1
Guadalajara 1
Gubbio 1
Huizen 1
Indianapolis 1
Totale 3.159
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 107
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 94
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 92
A high resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications 86
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 83
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 78
Endocrine tumors of the gastrointestinal system 75
A randomised, double-blind, trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over five years 72
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 70
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors 68
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 68
Ghrelin expression and actions. A novel peptide for an old cell type of the diffuse endocrine system 67
Unusual case of giant typical carcinoid tumor 66
Optimisation of isolation of richly pure and homogenous primary human colonic smooth muscle cells 65
Criteria for malignancy in gastrointestinal endocrine tumors 64
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor deficient mice. 64
Etiology, molecular pathogenesis and genetics 63
Linee guida e criteri diagnostici minimi per la diagnosi istologica dei tumori endocrini del tratto gastroenteropancreatico 61
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS -2- WELL-DIFFERENTIATED DUODENAL TUMOR/CARCINOMA (EXCLUDING GASTRINOMAS). 61
Consensus guidelines for the management of patients with digestive neuroendocrine tumors -4- well-differentiated pancreatic tumor/carcinoma: insulinoma. 61
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. 61
Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations 60
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 60
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 59
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 59
PYY-Tag transgenic mice displaying abnormal (H(+)-K(+)ATPase activity and gastric mucosal barrier impairment 58
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 58
Classification of the neuroendocrine phenotype in cancer 57
The phenotype of gut endocrine tumors 57
Anatomia patologica e tumori rari 56
CONSENSUS GUIDELINES ON THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS: WHY SUCH GUIDELINES AND HOW WE WENT ABOUT IT. 56
GI Tract, General Pathology of Endocrine Growths 55
Primary mixed adenocarcinoma and small cell carcinoma of the appendix. A clinicopathologic, immunohistochemical and molecular study of a hitherto unreported tumor 55
Autoimmune gastritis 55
Molecular aspects of the endocrine tumors of the pancreas and the gastrointestinal tract 55
Central Ghrelin gastroprotection involves nitric oxide/prostaglandins cross-talk. 55
Three different synchronous unilateral lung cancers: a case report 55
Ghrelin in gastroenteric pathophysiology 54
Characterisation of gastric ghrelin cells in man and other mammals – Studies in adult and foetal tissues 54
Epidemiology of carcinoid neoplasm in Vaud, Switzerland, 1974-1997 54
Unusual prostatic carcinoma with endocrine basophilic FSH-immunoreactive cells 53
Classification of neuroendocrine tumours. 53
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non small cell lung cancer(NSCLC) and fine needle aspirates from distant metastatic sites. 53
Il pancreas endocrino. 52
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract 52
Prognostic value of Goseki histological classification of adenocarcinoma of the cardia 52
Gastrinomas 51
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice 51
Introduction to a revised clinicopathological classification of the neuroendocrine tumors of the gastroenteropancreatic tract 51
Peptide YY expression is an early event in intestinal endocrine cell differentiation: evidence from normal and transgenic mice. 51
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. 51
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa 51
Solitary microcarcinoid of the rectal stump in ulcerative colitis. Case report 50
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinico-pathologic study. 50
Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. 50
Transient developmental expression of secretin in serotoninergic neurons of mouse brain 49
Mismatch repair system (MMR) status correlates with response and survival in non small cell lung cancer (NSCLC) patients. 49
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases 49
Highlights on biology of endocrine tumours of the gut and pancreas 49
Prognostic relevance of a novel TNM-classification system for gastroenteropancreatic neuroendocrine tumors of foregut origin 47
Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma 47
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system 46
Pathobiology and classification of digestive endocrine tumors 46
The endocrine pancreas 46
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE ENDOCRINE TUMORS -1- WELL-DIFFERENTIATED GASTRIC TUMORS/CARCINOMAS. 46
Prognostic factors in gastrointestinal endocrine tumors 46
Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells 46
The ontogeny and tissue specific regulation of ghrelin mRNA expression in the rat strongly indicate that ghrelin is primarily involved in the control of extraendocrine functions 45
Gastric endocrine cells: types function and growth 45
Dilated intercellular spaces as marker of reflux disease: histology, semiquantitative score and morphometry at light microscopy 44
Is TCRg clonality assay useful to detect early celiac disease? 44
Insulinoma 44
Effects of long-term esomeprazole treatment on the gastric mucosa 44
Endocrine tumours of the gut and pancreas tumor biology and classification 43
Évaluation de la malignité dans les tumeurs endocrines digestives: recommandations pratiques. 43
Ghrelin expression in gut endocrine tumours 42
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. 42
Gastroenteropancreatic neuroendocrine tumours. 42
Effect of CCK-B gastrin receptor blockade on chemically-induced colon carcinogenesis in mice: follow-up at 52 weeks 42
Pathology and biology of gastric neuroendocrine tumors in man 41
Vesicular monoamine transporter 2 as a marker of gastric ECL cell tumors 40
Origin and genetic background of insulinoma 39
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 39
Gastric neuroendocrine tumors - carcinoid and poorly differentiated carcinoma 38
The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. 38
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. 37
A Refractory pleural small cell carcinoma in never smoker. A case report. 37
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. 36
Development of neuroendocrine tumors in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. 36
Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active ß-catenin. 35
TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. 35
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. 34
Morphological, molecular, and prognostic aspects of gastric endocrine tumors 32
The normal endocrine cell of the gut. Changing concepts and new evidences 32
Dilated intercellular spaces: a major morphological feature of esophagitis. 32
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 32
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells 30
Neuroendocrine tumors: history and histopathology 29
Pancreatic endocrine tumors 29
Histogenesis, diagnosis and molecular basis of the endocrine tumors of the digestive tract and pancreas 29
Totale 5.185
Categoria #
all - tutte 17.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.154 0 220 102 42 130 151 162 21 107 101 23 95
2020/2021649 11 97 101 5 89 6 97 0 117 10 110 6
2021/2022455 4 1 0 28 17 6 67 97 18 36 63 118
2022/20231.595 197 156 62 129 155 173 15 101 551 10 38 8
2023/2024458 20 71 9 15 41 141 12 16 6 14 38 75
2024/202531 19 12 0 0 0 0 0 0 0 0 0 0
Totale 5.185